MarketPulse
E

$ETON

2 articles found
2 positive
0 negative
0 neutral
BenzingaBenzinga··Globe Newswire

Eton Pharmaceuticals Bolsters Rare Disease Portfolio With HEMANGEOL Acquisition

Eton Pharmaceuticals acquires HEMANGEOL commercialization rights, the only FDA-approved infantile hemangioma treatment, expanding its portfolio to ten commercial products with 2026 earnings accretion expected.
ETONrare diseaseorphan drug
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Eton Pharma Gains FDA Clearance for First Liquid Desmopressin Formulation

Eton Pharma gains FDA approval for DESMODA, the first liquid desmopressin formulation for central diabetes insipidus, launching March 9 with projected peak sales of $30-50 million.
ETONFDA approvalrare disease